GlassScriptPhysician profile
Maury Harden
NPI 1366157976
$873.64
in general payments reported to CMS, 2019-2025
19 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $375 · 2024: $257 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $780 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.64 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $150.31 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $102.82 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $87.02 | 2023 | Gemtesa, Myfembree |
| Millicent US INC | $59.09 | 2024-2025 | Intrarosa, Femlyv |
| Sage Therapeutics, LLC | $56.96 | 2023-2024 | |
| Shield Therapeutics INC | $55.52 | 2023-2024 | Accrufer |
| Baxter Healthcare | $52.53 | 2024-2025 | Perclot |
| Organon LLC | $45.41 | 2024-2025 | Nexplanon |
| Pfizer INC. | $35.70 | 2024 | |
| Hologic Sales and Service, LLC | $35.12 | 2023-2025 | Aptima, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $31.67 | 2023 | |
| Axsome Therapeutics, INC. | $27.43 | 2024 | Auvelity |
| Evofem Biosciences, INC. | $26.52 | 2025 | Solosec, Phexx, Phexxi |
| Bausch Health US, LLC | $20.76 | 2023 | Aplenzin, Wellbutrin |
| Abbvie INC. | $20.30 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vapotherm INC | $18.44 | 2023 | Vapotherm |
| Takeda Pharmaceuticals U.S.A., INC. | $16.80 | 2024 | Trintellix |
| Smith+Nephew, INC. | $16.21 | 2023 | Pico 14 |
| Myriad Women'S Health, INC. | $15.03 | 2023 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maury Harden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.